BlackRock Fund Advisors’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$319K Buy
10,458
+723
+7% +$18.4K ﹤0.01% 3320
2016
Q3
$265K Buy
9,735
+1,765
+22% +$49K ﹤0.01% 3362
2016
Q2
$228K Sell
7,970
-79,104
-91% -$2.52M ﹤0.01% 3406
2016
Q1
$2.63M Buy
87,074
+38
+0% +$1.08K ﹤0.01% 2996
2015
Q4
$3.02M Buy
87,036
+2,780
+3% +$95.1K ﹤0.01% 3039
2015
Q3
$3.19M Sell
84,256
-1,004
-1% -$46.7K ﹤0.01% 2997
2015
Q2
$4.86M Buy
85,260
+77,602
+1,013% +$4.42M ﹤0.01% 2938
2015
Q1
$446K Sell
7,658
-518
-6% -$27.8K ﹤0.01% 3287
2014
Q4
$464K Buy
8,176
+583
+8% +$27.8K ﹤0.01% 3280
2014
Q3
$311K Sell
7,593
-551
-7% -$25.3K ﹤0.01% 3316
2014
Q2
$371K Sell
8,144
-65,213
-89% -$2.74M ﹤0.01% 3273
2014
Q1
$3.48M Buy
73,357
+2,976
+4% +$135K ﹤0.01% 3008
2013
Q4
$3.31M Sell
70,381
-27,994
-28% -$1.22M ﹤0.01% 3028
2013
Q3
$3.92M Buy
98,375
+9,393
+11% +$369K ﹤0.01% 2957
2013
Q2
$3.17M Buy
+88,982
New +$3.41M ﹤0.01% 2958

Other funds holding HBIO